Sign Out
NINLARO is a cancer medicine that contains ixazomib, a 'proteasome inhibitor'.
NINLARO is used to treat multiple myeloma. Its active substance ixazomib works by blocking the action of proteasomes. These are structures inside the cell that digest proteins and are important for cell survival. Because myeloma cells produce a lot of proteins, blocking the action of proteasomes can kill the cancerous cells.
